Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:
Jan Alm: Declared to be a member of Merck Serono SA Advisory Board and receipt of consulting fees from Merck Serono SA.
Amaya Bélanger-Quintana: Declared to be a member of Merck Serono SA Advisory Board and receipt of consulting fees from Merck Serono SA.
Milan E. Blaskovics: Declared no potential conflict of interest.
Nenad Blau: Declared receipt of grants and contracts from Merck Serono SA, Switzerland.
Olaf Bodamer: Declared receipt of honoraria from Merck Serono SA.
Annet M. Bosch: Declared receipt of grants and contracts from SHS International and to be member of Merck Serono Advisory Board.
David P. Brenton: Declared no potential conflict of interest.
Alberto Burlina: Declared receipt of consulting fees from Merck Serono SA.
Barbara Burton: Declared receipt of grants, contracts honoraria or consultation fees from BioMarin Pharmaceutical and declared to participate in BioMarin Pharmaceutical Speaker’s Bureau.
Agnes Champigneulle: Declared to be an employee of Merck Serono SA.
Forrester Cockburn: Declared no potential conflict of interest.
Amy Cole: Declared receipt of honoraria from Merck Serono SA, Geneva.
Harold W. de Valk: Declared no potential conflict of interest.
Mübeccel Demirkol: Declared receipt of honoraria or consultation fees from Merck Serono SA, Geneva.
Steven F. Dobrowolski; Declared receipt of grants and contracts from National Institute of Health of the United States.
François Feillet; Declared to be a member of Merck Serono SA Advisory Board and the principal investigator for the KAMPER registry.
Reinhold Feldmann: Declared no potential conflict of interest.
Ivar Følling: Declared no potential conflict of interest.
Georg Frauendienst-Egger: Declared no potential conflict of interest.
Marcello Giovannini: Declared to be a member of PKU Advisory Board.
Richard Koch: Declared no potential conflict of interest.
Roland Kreis: Declared no potential conflict of interest.
Nicola Longo: Declared receipt of grants, contracts honoraria or consultation fees from BioMarin Pharmaceutical Inc.
Anita MacDonald: Declared receipt of grants and contracts from SHS International and Vitaflo and declared to be a member of Merck Serono Advisory Board.
Ania C. Muntau: Declared receipt of research grants for scientific work from SHS GmbH, Germany and from Merck Serono GmbH, Darmstadt. Declared to be a member of PKU Scientific Advisory Board and receipt of
honoraria from Merck Serono SA.
Charles R. Scriver: Declared receipt of grants and contracts from BioMarin, USA.
Isabel Smith: Declared no potential conflict of interest.
Friedrich K. Trefz: Declared receipt of honoraria or consultation fees from Merck Serono SA and to be a member of Merck Serono Advisory Board.
Francjan J. van Spronsen: Declared to be a member of Merck Serono Scientific Advisory Board for Phenylketonuria.
The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of January 13, 2010.
Flemming Güttler
Harvey L. Levy